View Expired Tender

Get immediate access to tenders like the one below by subscribing now to Tenders Direct. We will set up your personalised profile and send you tender alerts direct to your mailbox as soon as they are published. You will also benefit from having access to historical tenders.

Notice Summary

Title:
UK-Salisbury: PBL ICT Infrastructure (OJEU)
Document Ref:
GB003ZM317597
Document Type:
Contract Notice - Other
Published By:
Porton Biopharma
Date Published:
11 December 2019
Deadline Date:
24 January 2020
Document Source:
Framework/DPS:
No
Alert Profile:
Labels:

Notice Abstract

Porton Biopharma (PBL) is undertaking an extensive programme of work to create a new ICT core infrastructure, following the approval of a five-year technical Strategy by the business, mid-2019. Beginning with a limited scope ‘Pilot’ phase, the primary hosting and network solutions, cyber-security controls and use-cases must be trialled and refined. The duration of the Pilot is expected to be circa 6 months. Having been fully dependent on Public Health England (PHE) ICT services and infrastructure since its inception in 2015, it is strategically important for PBL to now establish a completely new and independent ICT operation. The following technical strategy has been approved for implementation. Within the limited scope of a Pilot phase, ICT services organisations are invited to express an interest in designing, supplying and building this environment in close collaboration with a dedicated PBL team, on a fixed-price basis. • HCI-based hosting platform – currently specified as Dell-EMC VxRail stretch-cluster. • Physical network underlay (limited scope). • Perimeter firewall (to be specified) • SDN network overlay technology (circa 30 endpoints) – currently specified as Cisco’s SDA solution. • Horizon VDI for application and desktop virtualisation (2 – 3 pilot application environments). • MS Windows domain(s) dedicated to PBL – including all domain-related services and inter-domain trust for testing purposes. • Coherent IDAM/RBAC ecosystem. The Pilot infrastructure will form the basis of a broader enterprise ICT core infrastructure that will be built-out in subsequent programme phases. PBL operates within a highly regulated pharmaceutical environment (within FDA and MHRA codes/guidance for GMP IT). Close collaboration with PBL and adherence to ITIL principles and local IT Infrastructure Qualification controls will be critical to ensure compliance with regulatory standards from day-one.

Notice Details

CONTRACT NOTICE – NATIONAL

SERVICES

1 Authority Details

1.1

Authority Name and Address

Porton Biopharma
N/A
Salisbury UK
Jeff Pike N/A
jeff.pike@portonbiopharma.com N/A

1.2

Address from which documentation may be obtained

As in 1.1

1.3

Completed documents must be returned to:

As in 1.1

2 Contract Details

2.1

Title

PBL ICT Infrastructure (OJEU)

2.2

Description of the goods or services required

Porton Biopharma (PBL) is undertaking an extensive programme of work to create a new ICT core infrastructure, following the approval of a five-year technical Strategy by the business, mid-2019. Beginning with a limited scope ‘Pilot’ phase, the primary hosting and network solutions, cyber-security controls and use-cases must be trialled and refined. The duration of the Pilot is expected to be circa 6 months.

Having been fully dependent on Public Health England (PHE) ICT services and infrastructure since its inception in 2015, it is strategically important for PBL to now establish a completely new and independent ICT operation.

The following technical strategy has been approved for implementation. Within the limited scope of a Pilot phase, ICT services organisations are invited to express an interest in designing, supplying and building this environment in close collaboration with a dedicated PBL team, on a fixed-price basis.

• HCI-based hosting platform – currently specified as Dell-EMC VxRail stretch-cluster.

• Physical network underlay (limited scope).

• Perimeter firewall (to be specified)

• SDN network overlay technology (circa 30 endpoints) – currently specified as Cisco’s SDA solution.

• Horizon VDI for application and desktop virtualisation (2 – 3 pilot application environments).

• MS Windows domain(s) dedicated to PBL – including all domain-related services and inter-domain trust for testing purposes.

• Coherent IDAM/RBAC ecosystem.

The Pilot infrastructure will form the basis of a broader enterprise ICT core infrastructure that will be built-out in subsequent programme phases.

PBL operates within a highly regulated pharmaceutical environment (within FDA and MHRA codes/guidance for GMP IT). Close collaboration with PBL and adherence to ITIL principles and local IT Infrastructure Qualification controls will be critical to ensure compliance with regulatory standards from day-one.

2.3

Notice Coding and Classification

2.4

Total quantity or scope of tender

3 Conditions for Participation

3.1

Minimum standards and qualification required

4 Administrative Information

4.1

Type of Procedure

The procedure type is unknown.

4.2

Reference number attributed to the notice by the contracting authority

project_5387

4.3

Time Limits

   24-01-2020  Time 17:00

4.5

Language or languages in which tenders or requests to participate can be drawn up

EN 

4.6

Tender Submission Postbox

5 Other Information

5.1

Additional Information

Please register on the following portal to view this notice:

https://phe.bravosolution.co.uk/esop/guest/login.do

-go to current opportunities

Listing Deadline: 24/01/2020 at 17:00 hrs

(MT Ref:317597)

5.2

Additional Documentation

5.3

Publication date of this notice

 10-12-2019

Current Notes